Global Oral Solid Dosage Pharmaceutical Formulation Market Professional Survey Report 2017

August 2017 | 118 pages | ID: GA520901CBFEN
QYResearch

Abstracts

This report studies Oral Solid Dosage Pharmaceutical Formulation in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• AstraZeneca Plc.
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• Gilead Sciences
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
• AbbVie Inc.
• Boehringer Ingelheim GmbH
• Hoffman-La-Roche Ltd.
• Johnson & Johnson
• Biogen Inc.
• Bayer AG
• Teva Pharmaceticals
• Amgen Inc.
• Takeda Pharmaceutical Company Ltd.
• Otsuka Pharmaceutical Co., Ltd.
• Shire Plc.
• Celgene Corporation
• Astellas Pharma Inc.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• By Form
• Capsules
• Powders
• Tablets
• By Drug Release Mechanism
• Immediate Release
• Extended Release

By Application, the market can be split into

• Hospitals
• Clinics
• Other

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Oral Solid Dosage Pharmaceutical Formulation Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION

1.1 Definition and Specifications of Oral Solid Dosage Pharmaceutical Formulation
  1.1.1 Definition of Oral Solid Dosage Pharmaceutical Formulation
  1.1.2 Specifications of Oral Solid Dosage Pharmaceutical Formulation
1.2 Classification of Oral Solid Dosage Pharmaceutical Formulation
  1.2.1 Capsules
  1.2.2 Powders
  1.2.3 Tablets
1.3 Applications of Oral Solid Dosage Pharmaceutical Formulation
  1.3.1 Hospitals
  1.3.2 Clinics
  1.3.3 Other
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Oral Solid Dosage Pharmaceutical Formulation
2.3 Manufacturing Process Analysis of Oral Solid Dosage Pharmaceutical Formulation
2.4 Industry Chain Structure of Oral Solid Dosage Pharmaceutical Formulation

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION

3.1 Capacity and Commercial Production Date of Global Oral Solid Dosage Pharmaceutical Formulation Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Oral Solid Dosage Pharmaceutical Formulation Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Oral Solid Dosage Pharmaceutical Formulation Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Oral Solid Dosage Pharmaceutical Formulation Major Manufacturers in 2016

4 GLOBAL ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Oral Solid Dosage Pharmaceutical Formulation Capacity and Growth Rate Analysis
  4.2.2 2016 Oral Solid Dosage Pharmaceutical Formulation Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate Analysis
  4.3.2 2016 Oral Solid Dosage Pharmaceutical Formulation Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Oral Solid Dosage Pharmaceutical Formulation Sales Price
  4.4.2 2016 Oral Solid Dosage Pharmaceutical Formulation Sales Price Analysis (Company Segment)

5 ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION REGIONAL MARKET ANALYSIS

5.1 North America Oral Solid Dosage Pharmaceutical Formulation Market Analysis
  5.1.1 North America Oral Solid Dosage Pharmaceutical Formulation Market Overview
  5.1.2 North America 2012-2017E Oral Solid Dosage Pharmaceutical Formulation Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Oral Solid Dosage Pharmaceutical Formulation Sales Price Analysis
  5.1.4 North America 2016 Oral Solid Dosage Pharmaceutical Formulation Market Share Analysis
5.2 China Oral Solid Dosage Pharmaceutical Formulation Market Analysis
  5.2.1 China Oral Solid Dosage Pharmaceutical Formulation Market Overview
  5.2.2 China 2012-2017E Oral Solid Dosage Pharmaceutical Formulation Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Oral Solid Dosage Pharmaceutical Formulation Sales Price Analysis
  5.2.4 China 2016 Oral Solid Dosage Pharmaceutical Formulation Market Share Analysis
5.3 Europe Oral Solid Dosage Pharmaceutical Formulation Market Analysis
  5.3.1 Europe Oral Solid Dosage Pharmaceutical Formulation Market Overview
  5.3.2 Europe 2012-2017E Oral Solid Dosage Pharmaceutical Formulation Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Oral Solid Dosage Pharmaceutical Formulation Sales Price Analysis
  5.3.4 Europe 2016 Oral Solid Dosage Pharmaceutical Formulation Market Share Analysis
5.4 Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Market Analysis
  5.4.1 Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Market Overview
  5.4.2 Southeast Asia 2012-2017E Oral Solid Dosage Pharmaceutical Formulation Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Oral Solid Dosage Pharmaceutical Formulation Sales Price Analysis
  5.4.4 Southeast Asia 2016 Oral Solid Dosage Pharmaceutical Formulation Market Share Analysis
5.5 Japan Oral Solid Dosage Pharmaceutical Formulation Market Analysis
  5.5.1 Japan Oral Solid Dosage Pharmaceutical Formulation Market Overview
  5.5.2 Japan 2012-2017E Oral Solid Dosage Pharmaceutical Formulation Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Oral Solid Dosage Pharmaceutical Formulation Sales Price Analysis
  5.5.4 Japan 2016 Oral Solid Dosage Pharmaceutical Formulation Market Share Analysis
5.6 India Oral Solid Dosage Pharmaceutical Formulation Market Analysis
  5.6.1 India Oral Solid Dosage Pharmaceutical Formulation Market Overview
  5.6.2 India 2012-2017E Oral Solid Dosage Pharmaceutical Formulation Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Oral Solid Dosage Pharmaceutical Formulation Sales Price Analysis
  5.6.4 India 2016 Oral Solid Dosage Pharmaceutical Formulation Market Share Analysis

6 GLOBAL 2012-2017E ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Oral Solid Dosage Pharmaceutical Formulation Sales by Type
6.2 Different Types of Oral Solid Dosage Pharmaceutical Formulation Product Interview Price Analysis
6.3 Different Types of Oral Solid Dosage Pharmaceutical Formulation Product Driving Factors Analysis
  6.3.1 By Form of Oral Solid Dosage Pharmaceutical Formulation Growth Driving Factor Analysis
  6.3.2 By Drug Release Mechanism of Oral Solid Dosage Pharmaceutical Formulation Growth Driving Factor Analysis

7 GLOBAL 2012-2017E ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Oral Solid Dosage Pharmaceutical Formulation Consumption by Application
7.2 Different Application of Oral Solid Dosage Pharmaceutical Formulation Product Interview Price Analysis
7.3 Different Application of Oral Solid Dosage Pharmaceutical Formulation Product Driving Factors Analysis
  7.3.1 Hospitals of Oral Solid Dosage Pharmaceutical Formulation Growth Driving Factor Analysis
  7.3.2 Clinics of Oral Solid Dosage Pharmaceutical Formulation Growth Driving Factor Analysis
  7.3.3 Other of Oral Solid Dosage Pharmaceutical Formulation Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION

8.1 AstraZeneca Plc.
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 AstraZeneca Plc. 2016 Oral Solid Dosage Pharmaceutical Formulation Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 AstraZeneca Plc. 2016 Oral Solid Dosage Pharmaceutical Formulation Business Region Distribution Analysis
8.2 Bristol-Myers Squibb Company
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Bristol-Myers Squibb Company 2016 Oral Solid Dosage Pharmaceutical Formulation Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Bristol-Myers Squibb Company 2016 Oral Solid Dosage Pharmaceutical Formulation Business Region Distribution Analysis
8.3 Eli Lilly and Company
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Eli Lilly and Company 2016 Oral Solid Dosage Pharmaceutical Formulation Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Eli Lilly and Company 2016 Oral Solid Dosage Pharmaceutical Formulation Business Region Distribution Analysis
8.4 Gilead Sciences
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Gilead Sciences 2016 Oral Solid Dosage Pharmaceutical Formulation Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Gilead Sciences 2016 Oral Solid Dosage Pharmaceutical Formulation Business Region Distribution Analysis
8.5 Merck & Co. Inc.
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Merck & Co. Inc. 2016 Oral Solid Dosage Pharmaceutical Formulation Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Merck & Co. Inc. 2016 Oral Solid Dosage Pharmaceutical Formulation Business Region Distribution Analysis
8.6 Novartis AG
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Novartis AG 2016 Oral Solid Dosage Pharmaceutical Formulation Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Novartis AG 2016 Oral Solid Dosage Pharmaceutical Formulation Business Region Distribution Analysis
8.7 Pfizer Inc.
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Pfizer Inc. 2016 Oral Solid Dosage Pharmaceutical Formulation Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Pfizer Inc. 2016 Oral Solid Dosage Pharmaceutical Formulation Business Region Distribution Analysis
8.8 AbbVie Inc.
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 AbbVie Inc. 2016 Oral Solid Dosage Pharmaceutical Formulation Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 AbbVie Inc. 2016 Oral Solid Dosage Pharmaceutical Formulation Business Region Distribution Analysis
8.9 Boehringer Ingelheim GmbH
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Boehringer Ingelheim GmbH 2016 Oral Solid Dosage Pharmaceutical Formulation Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Boehringer Ingelheim GmbH 2016 Oral Solid Dosage Pharmaceutical Formulation Business Region Distribution Analysis
8.10 Hoffman-La-Roche Ltd.
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Hoffman-La-Roche Ltd. 2016 Oral Solid Dosage Pharmaceutical Formulation Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Hoffman-La-Roche Ltd. 2016 Oral Solid Dosage Pharmaceutical Formulation Business Region Distribution Analysis
8.11 Johnson & Johnson
8.12 Biogen Inc.
8.13 Bayer AG
8.14 Teva Pharmaceticals
8.15 Amgen Inc.
8.16 Takeda Pharmaceutical Company Ltd.
8.17 Otsuka Pharmaceutical Co., Ltd.
8.18 Shire Plc.
8.19 Celgene Corporation
8.20 Astellas Pharma Inc.

9 DEVELOPMENT TREND OF ANALYSIS OF ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET

9.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Trend Analysis
  9.1.1 Global 2017-2022 Oral Solid Dosage Pharmaceutical Formulation Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Oral Solid Dosage Pharmaceutical Formulation Sales Price Forecast
9.2 Oral Solid Dosage Pharmaceutical Formulation Regional Market Trend
  9.2.1 North America 2017-2022 Oral Solid Dosage Pharmaceutical Formulation Consumption Forecast
  9.2.2 China 2017-2022 Oral Solid Dosage Pharmaceutical Formulation Consumption Forecast
  9.2.3 Europe 2017-2022 Oral Solid Dosage Pharmaceutical Formulation Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Oral Solid Dosage Pharmaceutical Formulation Consumption Forecast
  9.2.5 Japan 2017-2022 Oral Solid Dosage Pharmaceutical Formulation Consumption Forecast
  9.2.6 India 2017-2022 Oral Solid Dosage Pharmaceutical Formulation Consumption Forecast
9.3 Oral Solid Dosage Pharmaceutical Formulation Market Trend (Product Type)
9.4 Oral Solid Dosage Pharmaceutical Formulation Market Trend (Application)

10 ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKETING TYPE ANALYSIS

10.1 Oral Solid Dosage Pharmaceutical Formulation Regional Marketing Type Analysis
10.2 Oral Solid Dosage Pharmaceutical Formulation International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Oral Solid Dosage Pharmaceutical Formulation by Region
10.4 Oral Solid Dosage Pharmaceutical Formulation Supply Chain Analysis

11 CONSUMERS ANALYSIS OF ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Oral Solid Dosage Pharmaceutical Formulation
Table Product Specifications of Oral Solid Dosage Pharmaceutical Formulation
Table Classification of Oral Solid Dosage Pharmaceutical Formulation
Figure Global Production Market Share of Oral Solid Dosage Pharmaceutical Formulation by Type in 2016
Figure Capsules Picture
Table Major Manufacturers of Capsules
Figure Powders Picture
Table Major Manufacturers of Powders
Figure Tablets Picture
Table Major Manufacturers of Tablets
Table Applications of Oral Solid Dosage Pharmaceutical Formulation
Figure Global Consumption Volume Market Share of Oral Solid Dosage Pharmaceutical Formulation by Application in 2016
Figure Hospitals Examples
Table Major Consumers in Hospitals
Figure Clinics Examples
Table Major Consumers in Clinics
Figure Other Examples
Table Major Consumers in Other
Figure Market Share of Oral Solid Dosage Pharmaceutical Formulation by Regions
Figure North America Oral Solid Dosage Pharmaceutical Formulation Market Size (Million USD) (2012-2022)
Figure China Oral Solid Dosage Pharmaceutical Formulation Market Size (Million USD) (2012-2022)
Figure Europe Oral Solid Dosage Pharmaceutical Formulation Market Size (Million USD) (2012-2022)
Figure Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Market Size (Million USD) (2012-2022)
Figure Japan Oral Solid Dosage Pharmaceutical Formulation Market Size (Million USD) (2012-2022)
Figure India Oral Solid Dosage Pharmaceutical Formulation Market Size (Million USD) (2012-2022)
Table Oral Solid Dosage Pharmaceutical Formulation Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Oral Solid Dosage Pharmaceutical Formulation in 2016
Figure Manufacturing Process Analysis of Oral Solid Dosage Pharmaceutical Formulation
Figure Industry Chain Structure of Oral Solid Dosage Pharmaceutical Formulation
Table Capacity and Commercial Production Date of Global Oral Solid Dosage Pharmaceutical Formulation Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Oral Solid Dosage Pharmaceutical Formulation Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Oral Solid Dosage Pharmaceutical Formulation Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Oral Solid Dosage Pharmaceutical Formulation Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Oral Solid Dosage Pharmaceutical Formulation 2012-2017
Figure Global 2012-2017E Oral Solid Dosage Pharmaceutical Formulation Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Oral Solid Dosage Pharmaceutical Formulation Market Size (Value) and Growth Rate
Table 2012-2017E Global Oral Solid Dosage Pharmaceutical Formulation Capacity and Growth Rate
Table 2016 Global Oral Solid Dosage Pharmaceutical Formulation Capacity (K MT) List (Company Segment)
Table 2012-2017E Global Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate
Table 2016 Global Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) List (Company Segment)
Table 2012-2017E Global Oral Solid Dosage Pharmaceutical Formulation Sales Price (USD/MT)
Table 2016 Global Oral Solid Dosage Pharmaceutical Formulation Sales Price (USD/MT) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K MT) of Oral Solid Dosage Pharmaceutical Formulation 2012-2017E
Figure North America 2012-2017E Oral Solid Dosage Pharmaceutical Formulation Sales Price (USD/MT)
Figure North America 2016 Oral Solid Dosage Pharmaceutical Formulation Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K MT) of Oral Solid Dosage Pharmaceutical Formulation 2012-2017E
Figure China 2012-2017E Oral Solid Dosage Pharmaceutical Formulation Sales Price (USD/MT)
Figure China 2016 Oral Solid Dosage Pharmaceutical Formulation Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K MT) of Oral Solid Dosage Pharmaceutical Formulation 2012-2017E
Figure Europe 2012-2017E Oral Solid Dosage Pharmaceutical Formulation Sales Price (USD/MT)
Figure Europe 2016 Oral Solid Dosage Pharmaceutical Formulation Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K MT) of Oral Solid Dosage Pharmaceutical Formulation 2012-2017E
Figure Southeast Asia 2012-2017E Oral Solid Dosage Pharmaceutical Formulation Sales Price (USD/MT)
Figure Southeast Asia 2016 Oral Solid Dosage Pharmaceutical Formulation Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K MT) of Oral Solid Dosage Pharmaceutical Formulation 2012-2017E
Figure Japan 2012-2017E Oral Solid Dosage Pharmaceutical Formulation Sales Price (USD/MT)
Figure Japan 2016 Oral Solid Dosage Pharmaceutical Formulation Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K MT) of Oral Solid Dosage Pharmaceutical Formulation 2012-2017E
Figure India 2012-2017E Oral Solid Dosage Pharmaceutical Formulation Sales Price (USD/MT)
Figure India 2016 Oral Solid Dosage Pharmaceutical Formulation Sales Market Share
Table Global 2012-2017E Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) by Type
Table Different Types Oral Solid Dosage Pharmaceutical Formulation Product Interview Price
Table Global 2012-2017E Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) by Application
Table Different Application Oral Solid Dosage Pharmaceutical Formulation Product Interview Price
Table AstraZeneca Plc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Business Region Distribution
Table Bristol-Myers Squibb Company Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Business Region Distribution
Table Eli Lilly and Company Information List
Table Product A Overview
Table Product B Overview
Table 2015 Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Business Region Distribution
Table Gilead Sciences Information List
Table Product A Overview
Table Product B Overview
Table 2016 Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Business Region Distribution
Table Merck & Co. Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Business Region Distribution
Table Novartis AG Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis AG Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Novartis AG Oral Solid Dosage Pharmaceutical Formulation Business Region Distribution
Table Pfizer Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Business Region Distribution
Table AbbVie Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Business Region Distribution
Table Boehringer Ingelheim GmbH Information List
Table Product A Overview
Table Product B Overview
Table 2016 Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Business Region Distribution
Table Hoffman-La-Roche Ltd. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Business Region Distribution
Table Johnson & Johnson Information List
Table Biogen Inc. Information List
Table Bayer AG Information List
Table Teva Pharmaceticals Information List
Table Amgen Inc. Information List
Table Takeda Pharmaceutical Company Ltd. Information List
Table Otsuka Pharmaceutical Co., Ltd. Information List
Table Shire Plc. Information List
Table Celgene Corporation Information List
Table Astellas Pharma Inc. Information List
Figure Global 2017-2022 Oral Solid Dosage Pharmaceutical Formulation Market Size (K MT) and Growth Rate Forecast
Figure Global 2017-2022 Oral Solid Dosage Pharmaceutical Formulation Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Oral Solid Dosage Pharmaceutical Formulation Sales Price (USD/MT) Forecast
Figure North America 2017-2022 Oral Solid Dosage Pharmaceutical Formulation Consumption Volume (K MT) and Growth Rate Forecast
Figure China 2017-2022 Oral Solid Dosage Pharmaceutical Formulation Consumption Volume (K MT) and Growth Rate Forecast
Figure Europe 2017-2022 Oral Solid Dosage Pharmaceutical Formulation Consumption Volume (K MT) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Oral Solid Dosage Pharmaceutical Formulation Consumption Volume (K MT) and Growth Rate Forecast
Figure Japan 2017-2022 Oral Solid Dosage Pharmaceutical Formulation Consumption Volume (K MT) and Growth Rate Forecast
Figure India 2017-2022 Oral Solid Dosage Pharmaceutical Formulation Consumption Volume (K MT) and Growth Rate Forecast
Table Global Sales Volume (K MT) of Oral Solid Dosage Pharmaceutical Formulation by Type 2017-2022
Table Global Consumption Volume (K MT) of Oral Solid Dosage Pharmaceutical Formulation by Application 2017-2022
Table Traders or Distributors with Contact Information of Oral Solid Dosage Pharmaceutical Formulation by Region